tetraethylammonium has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Troncoso Brindeiro, CM | 1 |
| Fallet, RW | 1 |
| Lane, PH | 1 |
| Carmines, PK | 1 |
1 other study available for tetraethylammonium and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.
Topics: 4-Aminopyridine; Animals; Apamin; Arterioles; Bee Venoms; Diabetes Mellitus, Experimental; Diabetes | 2008 |